Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.
about
Medical management of brain tumors and the sequelae of treatment.Seizure prophylaxis for brain tumour patients. Brief review and guide for family physicians.Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies.Corticosteroids in brain cancer patients: benefits and pitfalls.Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre auditCollaboration in the presence of cerebral edema: The complications of steroids.Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapyClinical management of brain metastasis.Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.A review of the use of antiepileptic drugs in high-grade central nervous system tumors.Enzyme induction with antiepileptic drugs: cause for concern?Corticosteroid use in neuro-oncology: an update.Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study.Clinical Relevance of Steroid Use in Neuro-Oncology.An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.Seizure prophylaxis and melanoma brain metastases.
P2860
Q26992174-F607817D-34D3-49FF-95D6-3CFF6C5CA318Q30494448-68DDB903-5D05-45E2-8DF5-981AED4512DCQ33536015-A29EC09D-3A79-4FBB-9CBB-DF839BFD7553Q34191990-75413E6F-46C7-4169-9107-5715CF0D5472Q35826777-F48F37E6-8483-429D-B36C-6F15238FE8CCQ35999184-B52C261E-CA61-42D4-97D5-411D46E06585Q36893208-E3B58E14-4914-41F0-BBB1-0D2367A514A3Q36896269-37A757FA-F4E2-4EB1-93E3-82B245F2AB03Q37204965-A5B859C9-BFAA-4CA1-BEAA-D0FC5C35917EQ37987900-DE8671D4-F808-490A-9A68-A0B48A4A8CD1Q38046892-0BDE0AFB-59E7-4D59-839E-1CB085327FE6Q38512587-13784669-D1D4-41DD-8F80-973C7DE1A083Q38733792-ACB2BFBE-5F53-400A-93D5-A35E347B1C6AQ38990624-45C9F163-BBE8-4304-BD94-4752A88AE3F7Q41818795-F8C947BE-E968-49F9-99B7-8C6CE2459B10Q48670616-FFB1C821-BEAB-4737-A74A-A65E23C0D365
P2860
Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.
description
1984 nî lūn-bûn
@nan
1984 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Phenytoin impairs the bioavail ...... al and neurosurgical patients.
@ast
Phenytoin impairs the bioavail ...... al and neurosurgical patients.
@en
type
label
Phenytoin impairs the bioavail ...... al and neurosurgical patients.
@ast
Phenytoin impairs the bioavail ...... al and neurosurgical patients.
@en
prefLabel
Phenytoin impairs the bioavail ...... al and neurosurgical patients.
@ast
Phenytoin impairs the bioavail ...... al and neurosurgical patients.
@en
P2093
P356
P1476
Phenytoin impairs the bioavail ...... al and neurosurgical patients.
@en
P2093
P2860
P304
P356
10.1136/JNNP.47.10.1087
P407
P577
1984-10-01T00:00:00Z